Abiopharma

Director Khattar Jack A. 🟡 adjusted position in 1.5K shares (1 derivative) of SUPERNUS PHARMACEUTICALS, INC. (SUPN) at $45.00 Transaction Date: Aug 22, 2025 | Filing ID: 000006

New Form 144 - Alector, Inc. Filed: 2025-08-26 AccNo: 0001950047-25-006381 Size: 4 KB

New Form 8-K/A - Salarius Pharmaceuticals, Inc. Filed: 2025-08-26 AccNo: 0001615219-25-000115 Size: 564 KB Item 9.01: Financial Statements and Exhibits

Brailo Andy 🔴 sold 5.8K shares of Premier, Inc. (PINC) at $25.70 Transaction Date: Aug 22, 2025 | Filing ID: 000005

New Form 8-K - NovaBay Pharmaceuticals, Inc. Filed: 2025-08-26 AccNo: 0001829126-25-006735 Size: 220 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form PRE 14A - Entero Therapeutics, Inc. Filed: 2025-08-26 AccNo: 0001104659-25-083075 Size: 2 MB

New Form 6-K - Universe Pharmaceuticals INC Filed: 2025-08-26 AccNo: 0001213900-25-080750 Size: 10 KB

Director Hanson Jason David 🟢 acquired 8.5K shares of BullFrog AI Holdings, Inc. (BFRG) Transaction Date: Aug 22, 2025 | Filing ID: 025527

Guardant Health, Inc. - Guardant Health to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

Savara Inc. - Savara Announces Participation in Upcoming Investor Healthcare Conferences

Director Murphy-Chutorian Douglas 🟡 adjusted position in 28.6K shares (1 derivative) of Semler Scientific, Inc. (SMLR) at $30.54 ($1.2M) Transaction Date: Aug 25, 2025 | Filing ID: 083070

SmartVest - Electromed, Inc. Announces Record Fiscal 2025 Fourth Quarter and Full Year Financial Results

Sana Biotechnology to Present at September 2025 Investor Conferences

IRADIMED CORPORATION to Participate in the 2025 Wells Fargo Healthcare Conference

Seer to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference